Wells Fargo’s $60 target on BMY

BMY Bristol Myers Squibb

$57.6 → $60 (+4%) by Oct 2027

Equal Weight · lowers · said Oct 13, 2026 · 12-month default horizon

Open: judged on the close on Oct 13, 2027

The article this target came from

Wells Fargo cuts Bristol-Myers Squibb stock price target on Eliquis concerns

Investing.com · Oct 13, 2026

Wells Fargo lowered its price target on Bristol-Myers Squibb Co. (NYSE:BMY) to $60 from $65

Wells Fargo’s track record → Bristol Myers Squibb →

A fact about what Wells Fargo published, as reported by Investing.com, not a recommendation from Dalsna Finance; Wells Fargo is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.